Discover more news
John Whelan: Irish plants unlikely to escape Pfizer's latest round of cost-cutting
Business

John Whelan: Irish plants unlikely to escape Pfizer's latest round of cost-cutting

Irish Examiner logoIrish Examiner

Pharma giant plans to reduce costs by $2.5bn

Read on Irish Examiner